Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
294
-
Total 13F shares, excl. options
-
120M
-
Shares change
-
-4.39M
-
Total reported value, excl. options
-
$3.65B
-
Value change
-
-$117M
-
Put/Call ratio
-
2.35
-
Number of buys
-
145
-
Number of sells
-
-118
-
Price
-
$30.55
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q4 2024
357 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q4 2024.
Guardant Health, Inc. - Common Stock (GH) has 294 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 120M shares
of 124M outstanding shares and own 96.49% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (12.1M shares), BlackRock, Inc. (11.7M shares), Deep Track Capital, LP (6.42M shares), BAILLIE GIFFORD & CO (5.45M shares), CADIAN CAPITAL MANAGEMENT, LP (5.22M shares), WELLINGTON MANAGEMENT GROUP LLP (4.85M shares), Capital International Investors (4.47M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.81M shares), STATE STREET CORP (2.85M shares), and BRAIDWELL LP (2.85M shares).
This table shows the top 294 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.